NB
Healthcare & Life Sciences
NGM Biopharmaceuticals
United Statesngmbio.com
NGM Biopharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 3 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
3
Investors
About NGM Biopharmaceuticals
NGM Biopharmaceuticals is a startup based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
NGM Biopharmaceuticals develops antibody-based therapeutics targeting the GDF15 pathway to treat conditions such as hyperemesis gravidarum and cancer cachexia.
Explore NGM Biopharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.